Nutriband inc.NTRBW.US Overview
US StockHealthcare
(No presentation for NTRBW)
NTRBW Overall Performance
NTRBW AI Analysis & Strategy
NTRBW Recent Performance
-
Nutriband inc.
1.30%
Avg of Sector
0.61%
S&P500
NTRBW PowerScanner
NTRBW Key Information
NTRBW Valuation Metrics
NTRBW Earnings Table
NTRBW Profile
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.